Zimbabwe

in page functions
[French]
Zimbabwe
Total population (2018) 16,713,237
Birth cohort (2018) 535,834
Surviving Infants (surviving to 1 year per year, 2018) 515,149
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 47/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 71/1000
World Bank Index, IDA (2015) 2.86
Gross Nation Income (per capita US$, 2015) 860
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 63

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Zimbabwe

Type of support

Approvals

2001-2022 (US$)
(20 Jul 2018)

Commitments

2001-2022 (US$)
(20 Jul 2018)

Disbursements

2000-2018 (US$)
(20 Jul 2018)

% Disbursed

(20 Jul 2018)
2001 2002 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $107,975,787 $120,084,787 $110,463,430
Cash support (CASHSUPP) $170,000 $195,000 $170,000 100%
Health system strengthening (HSS 1) $7,427,786 $7,427,786 $7,087,786 95%
HPV (NVS) $2,540,500 $6,678,000 $2,536,040 100%
HPV Demo (NVS) $240,095 $240,095 $240,095 100%
HPV MAC (NVS) $6,111,500 $6,111,500 $6,098,700 100%
HPV MAC - Op costs (OPC) $385,626 $385,626 $385,626 100%
Immunisation services support (ISS) $1,529,848 $1,529,848 $1,529,848 100%
Injection Safety Devices (NVS) $327,435 $552,935 $402,904 123%
Injection safety support (INS) $948,925 $948,925 $948,925 100%
IPV (NVS) $839,759 $839,759 $37,259 4%
Measles (NVS) $504,000 $890,000 $340,268 68%
Measles-Rubella (NVS) $3,785,235 $3,785,235 $3,785,235 100%
MR - Operational costs (OPC) $3,407,312 $3,407,312 $3,407,312 100%
Penta (NVS) $28,783,773 $29,533,773 $28,959,313 101%
Pneumo (NVS) $40,067,552 $44,903,552 $43,445,968 108%
Rotavirus (NVS) $9,191,075 $10,940,075 $9,372,785 102%
Vaccine Introduction Grant (VIG) $1,715,366 $1,715,366 $1,715,366 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Zimbabwe DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 89%
M:F sex ratio at birth (2018) 1.02
Household survey: DTP3 coverage for male (2013) 87.40%
Household survey: DTP3 coverage for female (2013) 87.20%
Household survey: Last DTP3 survey (2013) 87%
% districts achieving > 80% DTP3 coverage (2017) 87%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 90%

Breakdown of support

Non-vaccine support Vaccine support
14% 86%
$15,244,863 $95,218,567

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Zimbabwe

02 May 2018

HPV vaccine's introduction into Zimbabwe's routine immunisation programme

Cervical cancer vaccine introduced in Zimbabwe

800,000 girls to be protected against disease following introduction of HPV vaccine.

17 July 2015

India pentavalent scale-up 2014

New coverage figures show more children than ever being reached with immunisation in poorest countries

Coverage trends heading in right direction but major differences remain between countries.

10 January 2013

mopan

GAVI recognised for effectiveness and focus on results

In its first ever Multilateral Organisation Performance Assessment Network (MOPAN) review the GAVI Alliance has been commended for its effectiveness in increasing access to immunisation and for its focus on results.

close icon

modal window here